← Back to Clinical Trials
RecruitingNCT06810258

BIOmarkers Before and After Kidney Transplantation

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionKidney Disease
SponsorAssistance Publique - Hôpitaux de Paris
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment1,000
SexALL
Min Age18 Years
Max AgeN/A
Start Date2024-10-08
Completion2034-10-08
Interventions
Blood sample during native kidney biopsyBlood sample during renal graft biopsyUrine sample during renal graft biopsy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In clinical nephrology, the search for urinary, blood and tissue biomarkers of specific kidney diseases is an important goal. In recent years, the use of these biomarkers has made it possible to diagnose many renal diseases that affect the native kidney. In some cases, biomarkers may be useful in determining the evolutionary profile of the disease and thus the most appropriate therapeutic management.

Eligibility Criteria

Inclusion Criteria: * Patient hospitalised for renal biopsy of a native kidney or for renal transplantation * Age \>18 years * Informed and consented * Covered by a social security scheme Exclusion criteria: * Patients under guardianship, conservatorship or legal protection * Pregnant or breastfeeding * Patient deprived of liberty * Patients of legal age who are unable to give consent

Related Trials